Table 1 Characteristics of management of uncomplicated UTI patients
From: Antibiotic treatment failure of uncomplicated urinary tract infections in primary care
Study characteristics | Total |
|---|---|
(n = 3194) | |
Primary care clinic, n (%) | |
Clinic A | 585 (18.3) |
Clinic B | 592 (18.5) |
Clinic C | 542 (17.0) |
Clinic D | 647 (20.3) |
Clinic E | 730 (22.9) |
Clinic F* | 98 (3.1) |
Year, n (%) | |
2019 | 1009 (31.6) |
2020 | 1035 (32.4) |
2021 | 1150 (36.0) |
Investigations performed, n (%) | |
Urine microscopy (UFEME) | 2236 (70.0) |
Urine dipstick | 74 (2.3) |
Both | 56 (1.8) |
None | 830 (26.0) |
No urine cultures | 2100 (65.7) |
Negative urine cultures | 684 (21.4) |
Positive urine cultures | 410 (12.8) |
Organisms in positive urine cultures, n (%) | |
Escherichia coli | 343 (64.6) |
Streptococcus agalactiae | 63 (11.9) |
Klebsiella pneumoniae | 45 (8.5) |
Staphylococcus saprophyticus | 31 (5.8) |
Proteus mirabilis | 16 (3.0) |
Citrobacter koseri | 14 (2.6) |
Others | 32 (6.0) |
Escherichia coli antibiotic susceptibility+, n (%) | |
Ampicillin | 195 (60.0) |
Amoxicillin-clavulanate | 300 (92.6) |
Ciprofloxacin | 260 (80.0) |
Ceftriaxone | 310 (95.4) |
Co-trimoxazole | 269 (82.5) |
Gentamicin | 306 (94.2) |
Nitrofurantoin | 318 (99.4) |
Pip/Tazobactam | 336 (98.2) |
Empirical antibiotics initiated, n (%) | |
Amoxicillin-clavulanate | 1164 (36.4) |
Nitrofurantoin | 1083 (33.9) |
Cotrimoxazole | 534 (16.7) |
Ciprofloxacin | 413 (12.9) |
Treatment failure, n (%) | |
Primary care | 123 (3.9) |
Hospital | 29 (0.9) |